AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) dropped 0.2% during trading on Friday . The stock traded as low as $18.37 and last traded at $18.78. 196,155 shares changed hands during trading, a decline of 26% from the average daily volume of 265,973 shares. The stock had previously closed at $18.82.
AGF U.S. Market Neutral Anti-Beta Fund Stock Down 0.2 %
The firm has a 50-day simple moving average of $18.44 and a 200-day simple moving average of $18.83. The stock has a market cap of $268.55 million, a PE ratio of 15.45 and a beta of -0.85.
Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund
Several institutional investors and hedge funds have recently bought and sold shares of the company. Triumph Capital Management purchased a new position in AGF U.S. Market Neutral Anti-Beta Fund during the third quarter worth about $1,064,000. Worth Asset Management LLC grew its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 26.4% during the fourth quarter. Worth Asset Management LLC now owns 51,594 shares of the company’s stock worth $875,000 after purchasing an additional 10,792 shares in the last quarter. Vermillion & White Wealth Management Group LLC bought a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund in the fourth quarter worth approximately $1,190,000. Finally, VitalStone Financial LLC raised its stake in AGF U.S. Market Neutral Anti-Beta Fund by 5,173.6% in the fourth quarter. VitalStone Financial LLC now owns 2,795 shares of the company’s stock valued at $47,000 after purchasing an additional 2,742 shares in the last quarter.
AGF U.S. Market Neutral Anti-Beta Fund Company Profile
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Further Reading
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- 3 Ways To Invest In Coffee, Other Than Drinking It
- MarketBeat Week in Review – 4/29 – 5/3
- What is a Low P/E Ratio and What Does it Tell Investors?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- NYSE Stocks Give Investors a Variety of Quality Options
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
